The U.S. Supreme Court on Monday let stand a lower court ruling saying Arkansas law requiring drug companies to offer ...

The U.S. Supreme Court on Monday declined to hear an appeal by the nation's leading drug industry group challenging an ...

Attorney General Tim Griffin said the decision by the court to uphold an Arkansas law passed in 2021 was a big win. The ...

Monday, the state of Arkansas claimed final victory in its legal battle with Big Pharma when the Supreme Court denied a ...

Issue: Whether the U.S. Court of Appeals for the 8th Circuit erred in holding that a state may strip manufacturers of the ability preserved to them by the federal 340B Drug Pricing Program to impose ...

The decision affirms a lower court's ruling that found no federal preemption of Arkansas' Act 1103, which restricts pharmaceutical manufacturers from limiting the ability of covered entities to use ...

Amid ongoing speculation about how the biopharmaceutical sector will fare under Donald Trump's second presidency, the ...

Attorney General Tim Griffin announces win in defending Arkansas’s drug access law. LITTLE ROCK, Ark. — On March 12, 2024, ...

The pharmaceutical industry is not lobbying senators to stop the confirmation of long-time critic Robert F. Kennedy Jr.

Sentiment towards digital and AI tech in the clinical research sector remains positive, with “slow and steady” uptake.

President-elect Trump hosted the chief executives of Pfizer, Eli Lilly and PhRMA Wednesday night at Mar-a-Lago, where they ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter ...